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Background: More than 90 % of uncomplicated upper respiratory tract infections are caused by viruses, with a risk
of developing subsequent bacterial infections in some patients. The risk of development of microbial complications
depends on the degree of viral damage of the structure of the respiratory mucosa and its functions.
The objective of this work was to study the effect of Sinupret oral drops on nasal mucosa atrophic changes in a rat
model of experimental rhinitis.
Methods: 60 female rats Wistar were allocated for the experimental study. To study the effect of phytopreparation
on atrophy of the nasal epithelium the animals were divided into 3 groups. The 1-st group (n = 20) was without
experimental acute rhinitis. The 2-nd group (n = 20) was with experimental acute rhinitis and without treatment
with Sinupret®. The 3-rd group (n = 20) with experimental acute rhinitis and treatment with Sinupret®. Experimental
rhinitis was induced by placing rats in a swimming pool with cold water, followed by a draught of cool air. The
effect of oral Sinupret treatment on histopathological changes in nasal mucosa was assessed on 3 and 14 days post
challenge. The results were analyzed using normal or modified Student’s t-test for independent groups.
Results: Histological evaluation demonstrated that Sinupret® oral drops applied during acute rhinitis attenuate
atrophic and destructive changes of the ciliated epithelium.
Conclusions: Oral administration of the herbal medicinal product Sinupret oral drops weakens atrophy of the nasal
mucosal ciliated epithelium in a rat model of acute rhinitis.
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Acute rhinitis is a typical feature of upper respiratory
tract infections (URTI), and is the most common inflam-
matory disorder of the upper air passages. More than
90 % of URTI are caused by viruses, with a risk of devel-
oping subsequent bacterial infections in some patients
[1]. The initial response of the nasal mucosa to the pres-
ence of a pathogen is an inflammatory reaction accom-
panied with mucus hypersecretion [1, 2], resulting in
increased mucus viscosity and eventually an impairment
of mucociliary clearance. Mucus accumulation in the air
passages promotes an extended contact of viruses or* Correspondence: yaremchuk191269@mail.ru
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ing pathogen colonization. Further sinuses and nasal
congestion due to a mucosal edema provokes a drop
in the tissue oxygen tension, and impairs the barrier
functions of the mucosa. Impaired mucus clearance and
a decrease in the partial pressure of oxygen are optimal
conditions for bacterial development and infections, thus
creating as a vicious circle of pathological processes [1, 2].
In the case of chronic inflammation, a diffuse metaplasia
turning functional columnar ciliated epithelium into
stratified multilayer epithelium occurs whereby the muco-
ciliary transport is impaired [2–5]. The herbal medicinal
product Sinupret®, composed of Gentianae radix, Primu-
lae flos cum calycibus, Sambuci flos, Rumicis herba and
Verbenae herba, is frequently used for the treatment of
acute or chronic rhinosinusitis [6, 7] due to its pleiotropics article distributed under the terms of the Creative Commons Attribution
y/4.0), which permits unrestricted use, distribution, and reproduction in any
credited.
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tion, and inflammation [9]. In addition, its beneficial im-
pact on mucociliary clearance was demonstrated in vivo in
mice and in in vitro experiments using respiratory epithe-
lial cells [10–12].
The aim of the current work was to investigate the ef-
fect of Sinupret® on the nasal mucosa, in particular the
ciliated epithelium, in a model of experimentally induced
acute rhinitis in rats.
Methods
Sixty female Wistar rats (body weight, 150 ± 20 g at
study start) were kept in the animal housing facility
under standard conditions in the Kiev National Univer-
sity. All the procedures were performed according to
Ukrainian and International guidelines for the use of an-
imals in research [13, 14].
After 1-week of acclimatization, the animals were ran-
domized into 3 groups. 1st group Control (CON) (n = 20;
no induction of experimental acute rhinitis (AR) and with-
out Sinupret® (SIN) treatment); 2nd group - AR (n = 20;
induction of experimental acute rhinitis without SIN treat-
ment); 3rd group AR + SIN (n = 20; induction of experi-
mental AR and treatment with SIN). Commercially
available Sinupret® Oral Drops were used throughout the
study. 100 g of Sinupret® Oral Drops (19 % ethanol (V/V))
contain 29 g of an aqueous-ethanol extract (extracting
agent: ethanol 59 % (V/V; drug/extract ratio 1:11) from
Gentianae radix, Primulae flos cum calycibus, Sambuci
flos, Rumicis herba and Verbenae herba in the fixed ratio
of 1:3:3:3:3.
SIN was orally administered to animals of the AR +
SIN group at a dose of one drop corresponding to a
human dose equivalent of 1.3 fold the recommended hu-
man dose. Upon allocation of the animals, experimental
AR was induced by placing the rats in a swimming pool
with cold water (+9 °C, 3 minutes), followed by an ex-
posure to a draught of cool air (+15 °C) for 5 minutes.
Nasal secretion began after 12 hours. Sinupret® was
administered directly after inducing AR in the animals
of AR and AR + SIN groups.
The animals were sacrificed by decapitation 3 and
14 days after study start (n = 10 group per occasion). For
morphological studies at day 3 and 14, nasal epithelium
was fixed in 10 % formalin solution. The samples were
embedded in paraffin, cut into 5 μm-paraffin sections
and stained with iron hematoxylin and hematoxylin-
eosin. Digital section micrographs were obtained by a
morphometric setup consisting of a microscope (PrimoStar,
Carl Zeiss) and digital camera (Tucsen). Cross-sectional
area of ciliated cell nuclei and goblet mucous cells and
height of the olfactory epithelium were assessed.
The data of each measured parameter in all experi-
mental groups was compared with the values from naïvecontrol group. In addition, data of the experimental
rhinitis groups (AR and AR + SIN) were compared.
Results were checked for normal distribution (Shapiro-
Wilk test) and for equality of variances (Levene’s test). The
results were analyzed using normal or modified Student’s t-
test for two independent groups. Non-normally distributed
data were analyzed with the Mann–Whitney U-test for two
independent groups. Differences were considered statisti-
cally significant for P < 0.05. Data are presented as means ±
standard error of the mean (SEM).
Results
The histopathological sequelae of experimental acute
rhinitis in rats were assessed on days 3 and 14 by cell
morphometric analysis of ciliated epithelial cells, inter-
calary epitheliocytes and goblet cells (Fig. 1, Table 1).
The results for the cell morphometric parameters are
listed in Table 1. At day 3, animals with experimental
AR without Sinupret® treatment displayed significantly
reduced respiratory epithelium height compared to con-
trol animals. Sinupret® treatment (SIN + AR) significantly
attenuated loss of epithelial height due to acute rhinitis
induction (p < 0.05 vs. AR) (Table 1, Fig. 1a-c). The
cross-sectional area of the nuclei of the ciliated cells
was significantly reduced following induction of acute
rhinitis compared to controls (Table 1, Fig. 1a-c). The
nuclei in the micrographs appeared dark and hyperchro-
mic (Fig. 1b). No significant differences were observed
between groups on day 3 on the cross-sectional area of
the goblet cells (Table 1, Fig. 1a-c).
After 14 days, the height of the respiratory epithelium in
the AR group was still reduced and the protective effect on
epithelial cells by Sinupret continued though this param-
eter did not reach statistical significance (not significant vs.
control) (Table 1, Fig. 1d-e). Concerning the cross-
sectional area of the nuclei of the ciliated cells, a significant
reduction was still present in the AR group, which was less
pronounced in the AR + SIN group (not significant vs. con-
trol) (Table 1). The nuclei of the AR group appeared dark
and hyperchromic. The cell nuclei in the AR + SIN group
were brighter, i.e. less hyperchromic (Fig. 1d-e).
In contrast to 3 day, at day 14 the cross-sectional area
of the goblet cells was significantly increased in animals
with acute rhinitis, independently of concomitant Sinu-
pret® treatment (Table 1).
Discussion
We employed a rat model of experimentally induced
(AR) to assess the effect of Sinupret treatment. Our data
demonstrate that the clinical symptoms such as sneezing
observed after the cool water/cool air protocol were as-
sociated with histopathological changes to the nasal mu-
cosal epithelium, mainly a reduction of epithelial height
and Goblet cell hypertrophy. Treatment with Sinupret
Fig. 1 REPRESENTATIVE MICROGRAPHS OF NASAL MUCOSAL EPITELIUM at day 3 (a: control; b: acute rhinitis, c: acute rhinitis + Sinupret) and day
14 (d: control; e: acute rhinitis; f: acute rhinitis + Sinupret) after induction of acute rhinitis or sham treatment. White arrows indicate the height of
the epithelial layer
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day 3 suggesting a protective effect of treatment against
the atrophy of the olfactory epithelium seen in the AR
group. After 14 days, there was still a marked difference
in epithelium height between control group and the AR
group. However the treatment group (AR + SIN) showed
no significant difference to the control at this time point.
The nuclei of the ciliated cells were of normal appear-
ance in the control group. In the AR group with induced
rhinitis, the nuclei appeared dark and hyperchromic at
day 3, suggesting reduced functionality. Interestingly at
day 14, the nuclei remained hyperchromic. In the active
treatment group (AR + SIN), the nuclei were brighter
than in the AR group, suggesting a partial reversal of the
acute rhinitis by the Sinupret® treatment.Table 1 Cell morphometric parameters of nasal mucosal epithelium
Sinupret treatment (AR + SIN) groups at day 3 and day 14 post chall
Day Experimental group Height of olfactory epithelium [μm
Day 3 Control 40,11 ± 1,99
Acute rhinitis 27,59 ± 1,13*
Acute rhinitis + Sinupret 35,84 ± 1,60#
Day 14 Control 40,08 ± 1,87
Acute rhinitis 28,82 ± 0,95*
Acute rhinitis + Sinupret 34,77 ± 2,07
Data are presented as means ± SEM from n = 10 animals/group
*р < 0,05 vs. control; #р < 0,05 vs. AR, Student´s t-testThe sectional area of the goblet cells increased both
in the AR and AR + SIN group compared to the con-
trol. This mucosal thickening indicates hypertrophy of
the cells due to the acute experimental rhinitis. The
use of the herbal drug did not prevent or change the
degree of hypertrophy of the mucous-producing gob-
let cells. Mucosal thickening has been described after
experimental acute sinusitis (bacterial Staphylococcus
aureus induction) in an animal model (rabbits) [15].
However, potential therapeutic effects of Sinupret on
mucociliary clearance via the recently described mech-
anisms of hydration of airway surface liquid and
stimulation of ciliary beat frequency [10, 12] were not
assessed in our model which focused on histological
alterations.in control (CON), acute rhinitis (AR) and acute rhinitis plus
enge
] Cross-sectional area of ciliated
cell nuclei [μm2]
Cross-sectional area of goblet
cells [μm2]
24,60 ± 1,32 126,52 ± 13,00
17,45 ± 0,75* 138,28 ± 20,34
18,68 ± 0,85* 164,36 ± 13,70
26,49 ± 1,07 130,50 ± 11,51
21,66 ± 0,99* 175,26 ± 12,42*
23,79 ± 1,13 174,30 ± 13,05*
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cinal product Sinupret® partially prevents atrophy of the
olfactory epithelium present in the course of acute ex-
perimental rhinitis in rats.
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